THE WHAT? The US Food and Drug Administration (FDA) has published its long-awaited assessment of per- and polyfluoroalkyl substances (PFAS) in cosmetic products, highlighting significant data gaps around their safety and use. THE DETAILS PFAS are a broad class of synthetic chemicals that are intentionally added to certain cosmetics—including colour cosmetics, skincare and nail…
THE WHAT? A Minnesota jury has awarded US$65.5 million in damages against Johnson & Johnson after finding that the company’s talc-based consumer products exposed a plaintiff to asbestos and contributed to her developing mesothelioma. THE DETAILS The verdict follows a 13-day trial in Ramsey County District Court, where jurors heard evidence that Johnson &…
THE WHAT? Shiseido has developed a new water-based sunscreen technology that maintains high UV protection and water resistance while adapting to changes in environmental humidity. THE DETAILS The oil-in-water technology uses soap-derived ingredients that react with metal ions in sweat and seawater to form a durable, water-repellent film on the skin. This enables long-lasting…
THE WHAT? The US Food and Drug Administration (FDA) has proposed adding bemotrizinol to the OTC sunscreen monograph, opening the door for its use as a permitted active ingredient in US sunscreens. THE DETAILS Under a proposed administrative order, the FDA would allow bemotrizinol at concentrations of up to 6% as a generally recognized…
THE WHAT? Beiersdorf has launched its dermatological skin care brand Eucerin in Japan, marking the brand’s entry into the world’s third-largest cosmetics market THE DETAILS The rollout is led by the Eucerin HARI FILLER anti-aging range, developed specifically for Japanese consumers by NIVEA-Kao. The premium line is positioned at the intersection of dermatological efficacy…
THE WHAT? Melt&Marble has secured €7.3 million in Series A funding to scale production of its precision-fermented fats and prepare for commercial launch in personal care. THE DETAILS The round was led by Industrifonden with participation from the EIC Fund, Beiersdorf, Valio, Catalyze Capital and Chalmers Ventures. Including recent EU grants, the company has…
THE WHAT? Cosmo Pharmaceuticals’ share price jumped 24% after the company reported statistically significant outcomes from two late-stage trials of its experimental male hair loss treatment. THE DETAILS The Switzerland-listed company announced that its clascoterone cream achieved major efficacy milestones in both Phase III studies. In one trial, patients recorded a 539% relative improvement…
THE WHAT? A new international study has identified significant rates of vascular occlusion linked to facial fillers, prompting calls for ultrasound mapping to prevent serious complications such as tissue damage and blindness. THE DETAILS Researchers reviewed 100 filler-related complication cases across six global centres from 2022 to 2025. Ultrasound scans showed nearly half had…